Jacobs Levy Equity Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Jacobs Levy Equity Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,574	Closed	-$241K	–	1114
2019 Q4	$241K	Buy	10,574 +8,750	+480%	+$125K	﹤0.01%	911
2019 Q3	$26K	Buy	+1,824	New	+$26.8K	﹤0.01%	908
2018 Q3	–	Sell	-3,744	Closed	-$160K	–	1093
2018 Q2	$160K	Sell	3,744 -986	-21%	-$45.2K	﹤0.01%	972
2018 Q1	$309K	Sell	4,730 -1,811	-28%	-$128K	0.01%	863
2017 Q4	$477K	Buy	6,541 +522	+9%	+$43.2K	0.01%	763
2017 Q3	$551K	Buy	6,019 +2,597	+76%	+$199K	0.01%	687
2017 Q2	$226K	Buy	3,422 +944	+38%	+$117K	﹤0.01%	813
2017 Q1	$537K	Sell	2,478 -964	-28%	-$138K	0.01%	655
2016 Q4	$318K	Buy	+3,442	New	+$388K	0.01%	758

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management's LUMO Position: Q1 2020 in Review

Jacobs Levy Equity Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 10,574 shares — an estimated $241K sold.

Jacobs Levy Equity Management first reported a position in LUMO in Q4 2016 and held it in 9 quarters. The position peaked at $551K in Q3 2017. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

Jacobs Levy Equity Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Jacobs Levy Equity Management sold 10,574 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $241K.
Jacobs Levy Equity Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2016 and held it in 9 quarters.
Jacobs Levy Equity Management's Lumos Pharma, Inc. Common Stock position peaked at $551K in Q3 2017.
46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2020, filed 15 May 2020.